Multicenter, Randomized, Non-comparative, Controlled Study of Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients With Long-term Viral Suppression.
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2014
At a glance
- Drugs HIV DNA vaccine (Primary) ; Maraviroc (Primary) ; Raltegravir (Primary) ; V 520 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms EraMune-02
- 10 Jun 2017 Biomarkers information updated
- 11 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.